Eidos治疗(EIDX)

122.21 0.00 0.0%

今开:0.0昨收:122.21
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4.74931561E9

Eidos治疗的热门评论

Eidos治疗(EIDX)2021-01-14 07:36

$Eidos治疗(EIDX)$ 内部交易: 2021-01-12,高级副总裁, Finance,Valle Franco ,卖出,1747普通股, $125.45查看全文

Eidos治疗(EIDX)2021-01-05 05:48

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-001014 Act: 34 Size: 20 KB 网页链接查看全文

Eidos治疗(EIDX)2019-11-28 10:10

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-19-028274 Size: 5 KB 网页链接查看全文

Eidos治疗(EIDX)2020-12-29 20:36

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-328268 Act: 34 Size: 9 MB 网页链接查看全文

Eidos治疗(EIDX)2020-12-29 05:42

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-327688 Act: 34 Size: 27 KB 网页链接查看全文

Eidos治疗(EIDX)2019-11-02 02:00

$Eidos治疗(EIDX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-10-31 AccNo: 0001564590-19-039169 Size: 9 MB 网页链接查看全文

Eidos治疗(EIDX)2020-12-15 22:36

$Eidos治疗(EIDX)$ DEFM14A Definitive proxy statement relating to merger or acquisition Accession Number: 0001193125-20-317643 Act: 34 Size: 3 MB 网页链接查看全文

Eidos治疗(EIDX)2020-12-17 08:33

$Eidos治疗(EIDX)$ 内部交易: 2020-12-15,Chief Business Officer,Turtle Cameron ,卖出,26294普通股, $111.77查看全文

Eidos治疗(EIDX)2020-12-17 08:33

$Eidos治疗(EIDX)$ 内部交易: 2020-12-15,Chief Business Officer,Turtle Cameron ,期权,26294普通股, $13.84查看全文

Eidos治疗(EIDX)2020-12-17 08:34

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-034181 Size: 18 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的最新评论

Eidos治疗(EIDX)2021-01-27 05:27

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 22:06

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 21:51

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 21:51

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-21 05:27

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的公告

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15